Collateral

Article

Oncology Decentralized Trials call for special consideration: Encapsia

Oncology Decentralized Trials call for special consideration: Encapsia

Encapsia spoke to Outsourcing-Pharma about some of the challenges unique to cancer-focused DCTs, and technologies that can help overcome some of these special obstacles.

Read more on Outsourcing Pharma

Article

The Source and the Story – How Digital Transformation Truly Centers Patients

The Source and the Story – How Digital Transformation Truly Centers Patients

This article is taken from International Clinical Trials February 2022, pages 8-10 © Samedan Ltd

Article

Predictions and perspectives on the future of DCTs

Predictions and perspectives on the future of DCTs

“The message was clear from industry leaders this year whether on social media or conferences: today’s clinical trials need decentralised solutions”, says Temitope Keyes, Executive Director Business Development at encapsia, commenting on the decentralised clinical trial (DCT) event horizon.

Read more on Drug Discovery World

Article

Updates Ready: Reboot Necessary

Updates Ready: Reboot Necessary

Clinical trials are now more complex than ever, and technology has not kept pace. Though a shift to digital decentralization has begun, all too often the solutions are just stitched onto already underperforming legacy systems.

Read more on The Medicine Maker

Article

Getting the right tech tools vital to decentralized trial transition

Getting the right tech tools vital to decentralized trial transition

Mark Tomlinson, Senior Director of Technology Operations at encapsia, explains how taking stock of existing tech and adding the right new tools can help when switching to virtual clinical studies.

Read more on Outsourcing Pharma

Article

Enabling Decentralized Clinical Trials through Digital Transformation

Enabling Decentralized Clinical Trials through Digital Transformation

To properly support and enable DCTs, we must undergo a digital transformation; we must eliminate the pain involved in aggregating and integrating data from multiple sources, reduce the lag between data capture and data analysis, and improve the ability of study teams to gain deeper insights and operationalize the data.

Read more on Contract Pharma

Article

Personalized Medicine: A Work in Progress

Personalized Medicine: A Work in Progress

Advances in big-data analytics are increasingly being employed to extract targeted information with the potential to drive life-sciences research and clinical practice closer to the goal of personalized and precision medicine.

Read more on PharmaVoice

Article

Clinical Trials in 3D – DCT, Data Science and Digital Transformation

Clinical Trials in 3D – DCT, Data Science and Digital Transformation

This article is taken from International Clinical Trials May 2021, pages 50-52. © Samedan Ltd.

Latest articles

Digital transformation can happen for any sponsor: How small and mid-sized biopharmaceutical companies can easily achieve digital innovation for their clinical data

In just a couple of decades, information technology has undergone a radical transformation –a sweeping evolution from floppy drives to data warehouses to data lakes. Our industry has unfortunately not ridden the arc of technology at the pace of other…

Read article

A better way to drive your digital transformation

As the ways in which clinical trials are conducted and monitored continue to modernize at pace, there is an urgent need for digital transformation in the industry. If sponsors are to realize their goals of running flexible, decentralized trials (DCT),…

Read article

Five predictions for the future of decentralized clinical trials

The message was clear from industry leaders last year – today’s clinical trials need decentralized solutions. More complexity means intensive data capture and continuous flows are essential, and vital strategic decisions rely on real-time data analysis and intelligence. Existing point…

Read article